Inside the growing bet that AI can find the patients pharma's failed trials missed...
AI-driven drug rescue could become a major biotech advantage by finding new uses and patient targets for previously abandoned compounds, reducing both cost and development time.
Thats right
AI-driven drug rescue could become a major biotech advantage by finding new uses and patient targets for previously abandoned compounds, reducing both cost and development time.
Thats right